Carol Lim, MD, MPH

  • 3Articles
  • 14.8KReads
  • 2022–2025Active
  • 8Collaborators
  • 8Citations

About

Carol Lim, MD, MPH, is affiliated with the Department of Psychiatry at Massachusetts General Hospital, Harvard Medical School, and North Suffolk Community Services in Boston, Massachusetts. Lim has published on clinical topics including schizophrenia and schizoaffective disorders, neurology, and seizures. Her work addresses issues such as clozapine-induced weight gain and its management with GLP-1 receptor agonists, paroxysmal eye movements in treatment-resistant schizophrenia, and the identification of seizure disorders exacerbating catatonia and schizophrenia. Lim has collaborated frequently with Oliver Freudenreich, Abigail L. Donovan, Cheryl Y. S. Foo, David Bargiela, and G. Kyle Harrold.

Publications

PCC
Tirzepatide for Clozapine-Induced Weight Gain
Case Report

Tirzepatide for Clozapine-Induced Weight Gain

July 8, 2025

The authors describe a patient with schizophrenia who effectively reversed substantial clozapine-induced weight gain using tirzepatide, followed by weight regain after insurance-related discontinuation.
, , , et al
PCC
Paroxysmal Eye Movements in Treatment-Resistant Schizophrenia
Case Report

Paroxysmal Eye Movements in Treatment-Resistant Schizophrenia

June 19, 2025

A patient with treatment-resistant schizophrenia whose presumed oculogyric crisis was later identified as seizure-like activity, worsened with clozapine and resolved with antiepileptic treatment.
, , , et al
PCC
Comprehensive Evaluation Detects Seizure Disorder That Exacerbated Catatonia and Treatment-Resistant Schizophrenia
Case Report

Comprehensive Evaluation Detects Seizure Disorder That Exacerbated Catatonia and Treatment-Resistant Schizophrenia

December 22, 2022

In this young man, continuous video-EEG monitoring revealed undiagnosed seizures that, once treated, helped resolve his catatonia and reduce symptoms of schizophrenia.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe